Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
117 hedge funds and large institutions have $242M invested in Dynavax Technologies in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 50 increasing their positions, 25 reducing their positions, and 21 closing their positions.
367% more call options, than puts
Call options by funds: $5.79M | Put options by funds: $1.24M
100% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 25
22.9% more ownership
Funds ownership: 80.93% → 103.83% (+23%)
15% more capital invested
Capital invested by funds: $210M → $242M (+$31.9M)
8% less funds holding
Funds holding: 127 → 117 (-10)
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$32.8M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$15.2M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$9.17M |
| 4 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
+$7.91M |
| 5 |
BlackRock
New York
|
+$6.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$8.12M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$7.65M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$6.53M |
| 4 |
Millennium Management
New York
|
-$5.39M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.52M |
DVAX Hedge Fund Activity: Q3 2019 in Review
117 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2019, worth a combined $242M — up 15% from $210M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of DVAX and 12 opened new positions — a net loss of 9 holders — while 25 trimmed existing stakes and 50 added.
The largest buyer was Bain Capital Life Sciences Investors, opening a new position worth an estimated $32.8M. The largest seller was Franklin Resources, cutting an estimated $8.12M.
- 117 institutional investors held Dynavax Technologies (DVAX) as of Q3 2019, down from 127 in Q2 2019.
- Funds reported $242M of Dynavax Technologies stock for Q3 2019, up 15% quarter-over-quarter.
- 12 funds opened new Dynavax Technologies positions in Q3 2019 and 21 closed out, a net change of -9 holders.
- The largest Dynavax Technologies buyer in Q3 2019 was Bain Capital Life Sciences Investors, an estimated $32.8M added.
- The largest Dynavax Technologies seller in Q3 2019 was Franklin Resources, an estimated $8.12M sold.
Based on aggregated 13F filings for Q3 2019.